Groesbeck Investment Management’s Genpact G Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$65K Sell
2,369
-163
-6% -$5.36K 0.1% 74
2026
Q1
$94K Hold
2,532
0.18% 72
2025
Q4
$118K Buy
+2,532
New +$110K 0.22% 69
2025
Q1
Sell
-4,938
Closed -$212K 86
2024
Q4
$212K Buy
+4,938
New +$208K 0.28% 83
2024
Q3
Sell
-7,831
Closed -$252K 70
2024
Q2
$252K Buy
+7,831
New +$253K 0.35% 63
2024
Q1
Sell
-6,688
Closed -$232K 96
2023
Q4
$232K Sell
6,688
-4,750
-42% -$164K 0.32% 73
2023
Q3
$414K Buy
11,438
+3,265
+40% +$121K 0.63% 59
2023
Q2
$307K Sell
8,173
-2,704
-25% -$109K 0.47% 62
2023
Q1
$503K Buy
+10,877
New +$508K 0.75% 50
2022
Q4
Sell
-11,326
Closed -$480K 83
2022
Q3
$480K Hold
11,326
0.79% 46
2022
Q2
$480K Sell
11,326
-1,199
-10% -$50.8K 0.79% 46
2022
Q1
$545K Buy
12,525
+800
+7% +$37.1K 0.61% 62
2021
Q4
$622K Buy
+11,725
New +$590K 0.79% 44

Other funds holding G

Groesbeck Investment Management's G Position: Q2 2026 in Review

Groesbeck Investment Management reduced its Genpact (G) stake by 6.4% in Q2 2026, selling an estimated $5.36K and leaving 2,369 shares worth $65K. The position accounts for 0.1% of the portfolio, ranked #74.

Groesbeck Investment Management first reported a position in G in Q4 2021 and has held it in 13 quarters since. The position peaked at $622K in Q4 2021. 89 funds tracked by Wall St. Rank hold G as of Q2 2026.

  • Groesbeck Investment Management held 2,369 shares of Genpact worth $65K as of Q2 2026.
  • Groesbeck Investment Management sold 163 Genpact shares in Q2 2026, an estimated $5.36K.
  • Genpact made up 0.1% of Groesbeck Investment Management's portfolio in Q2 2026, its #74 holding.
  • Groesbeck Investment Management first reported a position in Genpact in Q4 2021 and has held it in 13 quarters since.
  • Groesbeck Investment Management's Genpact position peaked at $622K in Q4 2021.
  • 89 funds tracked by Wall St. Rank held Genpact as of Q2 2026.

Based on Groesbeck Investment Management's 13F filing for Q2 2026, filed 15 Jul 2026.